Shutterstock
Pennsylvanians with asthma are seeing the price of their inhalers drop from $645 to $35, thanks to the Inflation Reduction Act.
Here’s who’s paying less for asthma inhalers, and why:
Who: In Pennsylvania, more than 1 million adults and 9% of kids suffer from asthma, according to the Centers for Disease Control and Prevention and the United Health Foundation.
What they’re saving on: Inhalers, which—until now—have been significantly overpriced in the US compared to other countries.
An investigation by the Democratic-led Senate Committee on Health, Education, Labor and Pensions noted that before the new price cap, drugmaker AstraZeneca charged $645 in the US for the same inhaler it charged $49 for in the United Kingdom.
What they cost now: Inhalers from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline have been capped to $35 a month.
The cost cap went into effect for AstraZeneca and Boehringer Ingelheim at the beginning of June. GlaxoSmithKline’s cap is expected to take effect by Jan. 1, 2025.
For AstraZeneca inhalers, both privately insured and uninsured patients will be eligible for the price cap.
For Boehringer Ingelheim inhalers, the $35 cap will be automatically applied at the pharmacy for the majority of patients with commercial insurance. Those without insurance can visit the company’s website where they can enroll for a copay card that will reduce the out-of-pocket cost to $35.
The price cap on GlaxoSmithKline inhalers will be available to all patients, regardless of insurance status.
What’s behind the price reduction?
The Inflation Reduction Act was largely touted as a win for climate change and clean
energy when President Joe Biden signed it into law in 2022. But it also included health care provisions that capped the cost of certain prescriptions for items such as insulin and inhalers.
Author
Support Our Cause
Thank you for taking the time to read our work. Before you go, we hope you'll consider supporting our values-driven journalism, which has always strived to make clear what's really at stake for Pennsylvanians and our future.
Since day one, our goal here at The Keystone has always been to empower people across the commonwealth with fact-based news and information. We believe that when people are armed with knowledge about what's happening in their local, state, and federal governments—including who is working on their behalf and who is actively trying to block efforts aimed at improving the daily lives of Pennsylvania families—they will be inspired to become civically engaged.
Medicaid patients treated at Crozer Health hospitals will have free access to medical records
The agreement will eliminate current per-record fees and is expected to go into effect soon. An agreement is being finalized that will eliminate...
Pa. nursing home operator Genesis enters bankruptcy with $58 million tax debt to state
The private-equity backed company operates 42 long-term care facilities in the commonwealth One of the largest nursing home operators in...
States can cut off Medicaid funding to Planned Parenthood, the Supreme Court rules
The ruling authored by Justice Neil Gorsuch and joined by the rest of the court's conservatives could have broader implications for Medicaid...
Gene editing helped a desperately ill Delaware County baby thrive. Scientists say it could someday treat millions
Researchers described the case in a new study, saying the baby is among the first to be successfully treated with a custom therapy that seeks to fix...
Opinion: My son relies on Medicaid for round-the-clock care. Republicans want to cut it.
Tax season has come and gone yet again, with millions of American families filing last month. But as my family took part in this annual ritual,...
